🚀 VC round data is live in beta, check it out!
S Biomedics Valuation Multiples
Discover revenue and EBITDA valuation multiples for S Biomedics and similar public comparables like Reig Jofré, Adagene, Oryzon Genomics, Binex and more.
S Biomedics Overview
About S Biomedics
S Biomedics Co Ltd is engaged in development, manufacturing and supply of stem cell treatment products, and main business is the production and sale of pharmaceutical products.
Founded
2003
HQ
Employees
54
Website
Sectors
Financials (FY)
EV
$258M
S Biomedics Financials
S Biomedics reported last fiscal year revenue of $11M and negative EBITDA of ($2M).
In the same fiscal year, S Biomedics generated $5M in gross profit, ($2M) in EBITDA losses, and had net loss of ($5M).
Revenue (LTM)
S Biomedics P&L
In the most recent fiscal year, S Biomedics reported revenue of $11M and EBITDA of ($2M).
S Biomedics expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $11M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $5M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 46% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($2M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (20%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (50%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($5M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (49%) | XXX | XXX | XXX |
| Net Debt | — | — | $3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
S Biomedics Stock Performance
S Biomedics has current market cap of $260M, and enterprise value of $258M.
Market Cap Evolution
S Biomedics' stock price is $21.75.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $258M | $260M | -2.2% | XXX | XXX | XXX | $-0.46 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialS Biomedics Valuation Multiples
S Biomedics trades at 23.1x EV/Revenue multiple, and (115.1x) EV/EBITDA.
EV / Revenue (LTM)
S Biomedics Financial Valuation Multiples
As of April 18, 2026, S Biomedics has market cap of $260M and EV of $258M.
Equity research analysts estimate S Biomedics' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
S Biomedics has a P/E ratio of (47.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $260M | XXX | $260M | XXX | XXX | XXX |
| EV (current) | $258M | XXX | $258M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 23.1x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (115.1x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (45.7x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 50.6x | XXX | XXX | XXX |
| P/E | — | XXX | (47.3x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (45.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified S Biomedics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
S Biomedics Margins & Growth Rates
S Biomedics' revenue in the last fiscal year grew by 20%.
S Biomedics' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
S Biomedics Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 20% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (20%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 2% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 6% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 10% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 55% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 96% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
S Biomedics Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| S Biomedics | XXX | XXX | XXX | XXX | XXX | XXX |
| Reig Jofré | XXX | XXX | XXX | XXX | XXX | XXX |
| Adagene | XXX | XXX | XXX | XXX | XXX | XXX |
| Oryzon Genomics | XXX | XXX | XXX | XXX | XXX | XXX |
| Binex | XXX | XXX | XXX | XXX | XXX | XXX |
| Transgene | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
S Biomedics M&A Activity
S Biomedics acquired XXX companies to date.
Last acquisition by S Biomedics was on XXXXXXXX, XXXXX. S Biomedics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by S Biomedics
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialS Biomedics Investment Activity
S Biomedics invested in XXX companies to date.
S Biomedics made its latest investment on XXXXXXXX, XXXXX. S Biomedics invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by S Biomedics
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout S Biomedics
| When was S Biomedics founded? | S Biomedics was founded in 2003. |
| Where is S Biomedics headquartered? | S Biomedics is headquartered in South Korea. |
| How many employees does S Biomedics have? | As of today, S Biomedics has over 54 employees. |
| Is S Biomedics publicly listed? | Yes, S Biomedics is a public company listed on Korea Exchange. |
| What is the stock symbol of S Biomedics? | S Biomedics trades under 304360 ticker. |
| When did S Biomedics go public? | S Biomedics went public in 2023. |
| Who are competitors of S Biomedics? | S Biomedics main competitors are Reig Jofré, Adagene, Oryzon Genomics, Binex. |
| What is the current market cap of S Biomedics? | S Biomedics' current market cap is $260M. |
| What is the current revenue of S Biomedics? | S Biomedics' last fiscal year revenue is $11M. |
| What is the current EV/Revenue multiple of S Biomedics? | Current revenue multiple of S Biomedics is 23.1x. |
| Is S Biomedics profitable? | No, S Biomedics is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.